INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.70 Cr | ₹-0.66 Cr | ₹-0.59 Cr | ₹-0.42 Cr | ₹-0.26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of INDO US BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.70 Cr |
| Mar2024 | ₹-0.66 Cr |
| Mar2023 | ₹-0.59 Cr |
| Mar2022 | ₹-0.42 Cr |
| Mar2021 | ₹-0.26 Cr |
How is Deferred Tax Assets / Liabilities of INDO US BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.70 Cr | Negative | |
| Mar2024 | ₹-0.66 Cr | Negative | |
| Mar2023 | ₹-0.59 Cr | Negative | |
| Mar2022 | ₹-0.42 Cr | Negative | |
| Mar2021 | ₹-0.26 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹162.8 Cr | -3.3% | -6.3% | -53.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,932.5 Cr | -1.7% | -11.7% | -30.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,218.1 Cr | 0.8% | 11.8% | 3.4% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,093.4 Cr | 1.4% | 2.5% | -4.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹944.4 Cr | 4.9% | 0.1% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹479.8 Cr | -6% | -12.8% | -14.6% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -3.3% |
-6.3% |
-53.5% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses